COMMD1 regulates inflammation and colitis-associated cancer progression

14Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

NF-κB is a master transcriptional regulator of inflammation that plays an important role in oncogenesis, particularly in tumors that arise in the context of inflammation. Copper metabolism MURR1 domain-containing 1 (COMMD1) is a negative regulator of NF-κB. Recent genetic-based studies in both mice and human patients indicate that COMMD1 has an important role in controlling intestinal inflammation and constraining progression to colitis-associated cancer.

Cite

CITATION STYLE

APA

Li, H., & Burstein, E. (2014). COMMD1 regulates inflammation and colitis-associated cancer progression. OncoImmunology, 3(7). https://doi.org/10.4161/21624011.2014.947891

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free